Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma.
Ferreri
A J M
AJ
Dognini
G P
GP
Ponzoni
M
M
Pecciarini
L
L
Cangi
M G
MG
Santambrogio
G
G
Resti
A G
AG
De Conciliis
C
C
Magnino
S
S
Pasini
E
E
Vicari
N
N
Dolcetti
R
R
Doglioni
C
C
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002691:Chlamydophila psittaci / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D009956:Psittacosis / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D040521:Subcutaneous Tissue
D000900:Anti-Bacterial Agents; D004318:Doxycycline